ITGAX and neoplasm: Increases in terms of fold changes in CD4/CD8+ T cells and CD11c+ DCs in the lung metastatic sites were significantly higher than those in the primary tumor (CD8+ T cells: p = 0.019, CD4+ T cells: p = 0.004, CD11c+ DCs: p = 0.017).